These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4154799)

  • 1. Differential effects of neuroleptic drugs on amphetamine-induced stimulation of locomotor activity in 11-day-old and adult rats.
    Miller R; Sahakian B
    Brain Res; 1974 Dec; 81(2):387-92. PubMed ID: 4154799
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity.
    Bunney BS; Walters JR; Roth RH; Aghajanian GK
    J Pharmacol Exp Ther; 1973 Jun; 185(3):560-71. PubMed ID: 4576427
    [No Abstract]   [Full Text] [Related]  

  • 3. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM
    Arzneimittelforschung; 1967 Jul; 17(7):841-54. PubMed ID: 5632842
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioral depression and its neurochemical correlates at high doses of d-amphetamine in rats.
    Copeland RL; Aulakh CS; Bhattacharyya AK; Pradhan SN
    Neuropharmacology; 1980 Oct; 19(10):1027-30. PubMed ID: 7191484
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats.
    Rolinski Z; Scheel-Krüger J
    Acta Pharmacol Toxicol (Copenh); 1973; 33(5):385-99. PubMed ID: 4149038
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment.
    Vonvoigtlander PF; Losey EG; Triezenberg HJ
    J Pharmacol Exp Ther; 1975 Apr; 193(1):88-94. PubMed ID: 166158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced locomotor activity following amphetamine in mouse-killing rats.
    Salama AI; Goldberg ME
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):162-9. PubMed ID: 4795753
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine antagonism and antischizophrenic potency of neuroleptic drugs.
    Crow TJ; Gillbe C
    Nat New Biol; 1973 Sep; 245(140):27-8. PubMed ID: 4516939
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific antagonism by dopamine inhibitors of items of amphetamine induced aggressive behaviour.
    Hasselager E; Rolinski Z; Randrup A
    Psychopharmacologia; 1972; 24(4):485-95. PubMed ID: 5064290
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of pharmacologic substances on the sequelae of emotional excitation in cats].
    Burov IuV; Salimov RM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1974; 24(4):825-32. PubMed ID: 4155848
    [No Abstract]   [Full Text] [Related]  

  • 13. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.
    Creese I; Iversen SD
    Brain Res; 1973 Jun; 55(2):369-82. PubMed ID: 4145950
    [No Abstract]   [Full Text] [Related]  

  • 14. Interactions of various drugs with amphetamine.
    Garattini S; Jori A; Samanin R
    Ann N Y Acad Sci; 1976; 281():409-25. PubMed ID: 798529
    [No Abstract]   [Full Text] [Related]  

  • 15. Partial restoration by a neuroleptic (spiramide) of items of grooming behaviour suppressed by amphetamine.
    Kjellberg B; Randrup A
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):61-6. PubMed ID: 4474849
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in dopamine-mediated behaviour during one year's neuroleptic administration.
    Clow A; Jenner P; Marsden CD
    Eur J Pharmacol; 1979 Aug; 57(4):365-75. PubMed ID: 39769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of withdrawal from chronic amphetamine administration on activity levels of albino rats.
    Houser VP; Van Hart DA
    Psychol Rep; 1974 Aug; 35(1):307-10. PubMed ID: 4472602
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimuscarinic actions of neuroleptic drugs.
    Miller R; Hiley R
    Adv Neurol; 1975; 9():141-54. PubMed ID: 167564
    [No Abstract]   [Full Text] [Related]  

  • 19. A dissociation of the effects of d-amphetamine on locomotor activity and exploration in rats.
    Robbins T; Iversen SD
    Psychopharmacologia; 1973 Jan; 28(2):155-64. PubMed ID: 4694624
    [No Abstract]   [Full Text] [Related]  

  • 20. Thigmotaxis as a test for anxiolytic activity in rats.
    Treit D; Fundytus M
    Pharmacol Biochem Behav; 1988 Dec; 31(4):959-62. PubMed ID: 3252289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.